We’ve long been saying so, and the issue has made headlines many times in recent months; now PLoS Medicine is writing that ties between Big Pharma and health professionals—are not sufficiently broad, reports Science Daily. In this case, the issue concerns Australian reporting standards; however, the problem has been noted in a variety of global sites, including the United States.
David Henry, from the Institute for Clinical Evaluative Sciences in Toronto, Canada, and colleagues, looked at information released by Medicines Australia, which is that country’s “pharmaceutical industry representative body,” said Science Daily. Since 2007, Medicines Australia has been mandated to report information from “industry-sponsored function and educational event for health professionals,” explained Science Daily. The information must also include the event’s venue, cost, attendees, and “hospitality” provided, but does not require disclosure regarding speaker names, finances transacted between industry and speakers, and the companies’ part in selecting a speaker, noted Science Daily. (more…)

